LifeScan, a leader in blood glucose monitoring and maker of the OneTouch® brand announced it has entered into an exclusive agreement with Sanvita
DarioHealth Corp., today announced a joint marketing agreement with Glytec, a pioneer of insulin titration solutions. The agreement allows
Senseonics Holdings, Inc., a medical technology company developing a long-term, implantable continuous glucose monitoring (CGM) system for people
Senseonics Holdings, Inc. announced the integration of Eversense CGM data into the Glooko diabetes data management platform. Senseonics is focused on
Abbott and Novo Nordisk today announced a deal that connects two key technologies: Continuous glucose monitoring (CGM) and connected insulin pens.
Senseonics Holdings, Inc., a company developing long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced
Senseonics Holdings, Inc., announced it will extend its agreement with Roche Diabetes Care to sell its implantable continuous glucose monitoring
A new mobile app for Abbott’s Freestyle Libre 10-day and 14-day glucose monitoring systems has been approved for use in the U.S. by the FDA. It
Senseonics Holdings, Inc. announced that the FDA has approved the insertion and removal of its Eversense® Continuous Glucose Monitoring (CGM)
One Drop expands their industry leading Apple Watch diabetes management solution by offering the first and only wireless blood glucose monitoring
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: